Internal Server Error

Reverie Labs - About the company

Reverie Labs is an acquired company based in Boston (United States), founded in 2017 by Hirsh Jain, Jonah Kallenbach and Ankit Gupta. It operates as a Provider of an AI based molecular modelling and optimization software for research & development. Reverie Labs has raised $32M in funding from Rough Draft Ventures and Ridgeback Capital Management. The company has 212 active competitors, including 71 funded and 13 that have exited. Its top competitors include companies like Schrodinger, Recursion Pharmaceuticals and Valo Health.

Company Details

Reverie Labs is a company focusing on accelerating the drug design pipeline. The company uses machine learning technology for lead generation and optimization. The company has developed structure-based predictive models for potency and ADME/PK properties of the small molecule. Additionally, the company also serves custom model requests.
Social
XFacebook
Email ID
*****@reverielabs.com
Part Of
Registered Address
678 Massachusetts Ave Cambridge, MA 02139
Key Metrics
Founded Year
2017
Location
Boston, United States
Stage
Acquired
Total Funding
$32M in 2 rounds
Latest Funding Round
Ranked
Employee Count
4 as on Jun 30, 2026
Similar Companies
Exit Details
Acquired by Ginkgo Bioworks (Feb 28, 2024)

Reverie Labs's acquisition details

Reverie Labs got acquired by Ginkgo Bioworks on Feb 28, 2024.
Click here to take a look at Reverie Labs's acquisition in detail
Sign up to download Reverie Labs' company profile

Reverie Labs's funding and investors

Reverie Labs has raised a total funding of $32M over 2 rounds. Its first funding round was on 2017. Its latest funding round was a Series A round on Feb 03, 2021 for $*****. 3 investors participated in its latest round. Reverie Labs has 16 institutional investors.

Here is the list of recent funding rounds of Reverie Labs:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Feb 03, 2021
5283953
Series A
5191539
3555128
2125489
5095672
2017
8043
Seed
3354
3840
6283
lockAccess funding benchmarks and valuations. Sign up today!

Reverie Labs' founders and board of directors

Founder? Claim Profile
The founders of Reverie Labs are Hirsh Jain, Jonah Kallenbach and Ankit Gupta. Jonah Kallenbach is the CEO of Reverie Labs.
Here are the details of Reverie Labs' key team members:

Reverie Labs' employee count trend

Reverie Labs has 4 employees as of Jun 26. Here is Reverie Labs's employee count trend over the years:
Employee count trend for Reverie Labs
lockUncover Reverie Labs' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Reverie Labs's Competitors and alternates

Top competitors of Reverie Labs include Schrodinger, Recursion Pharmaceuticals and Valo Health. Here is the list of Top 10 competitors of Reverie Labs, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Schrodinger
Schrodinger
1990, New York City (United States), Acquired
Provider of a web-based simulation and modelling tool
$162M
74/100
2nd
AI-enabled drug discovery and development platform for novel therapeutics
$452M
72/100
3rd
Logo for Valo Health
Valo Health
2019, Boston (United States), Series B
AI-powered platform for drug discovery and development
$450M
67/100
4th
Logo for XtalPi
XtalPi
2014, Cambridge (United States), Public
AI-based drug research and development company
$785M
67/100
5th
Logo for Isomorphic Labs
Isomorphic Labs
2021, London (United Kingdom), Series B
Digital platform focused on revolutionizing drug discovery using AI
$2.7B
64/100
6th
Logo for Xaira
Xaira
2023, San Francisco (United States), Series D
AI-enabled platform for drug discovery and development
$1B
63/100
7th
Logo for In Silico
In Silico
2014, Cambridge (United States), Public
AI-enabled bioinformatics platform for drug discovery and biomarker development
$510M
62/100
8th
Logo for Tandem AI
Tandem AI
2021, New York (United States), Series A
AI-based drug discovery tool for researchers
$82M
62/100
9th
Logo for Causaly
Causaly
2018, London (United Kingdom), Series B
Provider of an AI platform for life sciences and biomedical research
$93M
62/100
10th
Logo for Aqemia
Aqemia
2019, Paris (France), Series A
Provider of an AI and quantum physics to discover therapeutic molecules
$101M
62/100
41st
Logo for Reverie Labs
Reverie Labs
2017, Boston (United States), Acquired
Provider of an AI based molecular modelling and optimization software for research & development
$32M
47/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Reverie Labs's competitors? Click here to see the top ones

Reverie Labs's Investments and acquisitions

Reverie Labs has made no investments or acquisitions yet.

Reports related to Reverie Labs

Here is the latest report on Reverie Labs's sector:

News related to Reverie Labs

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Reverie Labs

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford